go back

Revefenacin (Yupelri) Inhalation Solution

Kansas rates for HCPCS J7677

Revefenacin inhalation solution, FDA-approved final product, noncompounded, administered through DME, 1 mcg

Rates data updated July 2026.

Facilitymedian $0 · 10th–90th $0$10%20%40%10th90th$0Professionalmedian $0 · 10th–90th $0$00%50%90th$0$0.0$0.1$0.5$2.0$10.0$50.0

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$0.06
Median
$0.23
Typical High
$0.87
Aetna
Setting
Professional
Modifier
Global
Typical Low
$0.20
Median
$0.21
Typical High
$0.27
BCBS
Setting
Facility
Modifier
Global
Typical Low
$0.24
Median
$0.25
Typical High
$0.25
BCBS
Setting
Professional
Modifier
Global
Typical Low
$0.20
Median
$0.20
Typical High
$0.20
Cigna
Setting
Facility
Modifier
Global
Typical Low
$0.20
Median
$0.32
Typical High
$0.71
Cigna
Setting
Professional
Modifier
Global
Typical Low
$0.20
Median
$0.20
Typical High
$0.31
Medica
Setting
Facility
Modifier
Global
Typical Low
$0.19
Median
$0.20
Typical High
$85.11
Medica
Setting
Professional
Modifier
Global
Typical Low
$0.16
Median
$0.19
Typical High
$0.30
United
Setting
Facility
Modifier
Global
Typical Low
$0.08
Median
$0.20
Typical High
$0.20
United
Setting
Professional
Modifier
Global
Typical Low
$0.08
Median
$0.20
Typical High
$0.33